View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 3.0 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Daiichi Sankyo, Inc., Seattle Genetics, and Takeda Oncology.

T-Cell Lymphoma Tumor Board: Application of Novel Agents for the Treatment of PTCL and CTCL

T-Cell Lymphoma Tumor Board: Application of Novel Agents for the Treatment of PTCL and CTCL

Friday, December 4, 2020

Live, Interactive Virtual Conference!

11:00am - 2:00pm PST


T-cell lymphomas (TCLs) are a set of non-Hodgkin lymphomas (NHLs) that account for an estimated 5% to 20% of all NHL cases in Western countries. Common subtypes of peripheral T-cell lymphomas (PTCLs) include PTCL not otherwise specified, which is the most aggressive of all lymphoid neoplasms. In addition, a separate set of cutaneous T-cell lymphomas (CTCL) exist. There are over 10 subtypes of CTCL, with mycosis fungoides (MF) as the most common variant of CTCL, representing about 50% of all cases.

The rapid pace and sheer volume of basic science and therapeutic developments that continue to emerge related to TCL therapeutics has continued to create practice and/or educational gaps for oncologists and the multidisciplinary team who strive to maintain state-of-the-art care and counseling for their patients. In addition to these therapeutic advances, the past several years have brought advances in understanding the pathobiology of PTCL and CTCL and their management. These advances have resulted in a shift to personalized strategies that recognize these tumors as a heterogeneous group of diseases.

T-Cell Lymphoma Tumor Board: Application of Novel Agents for the Treatment of PTCL and CTCL is a CME-certified live webcast to be held on Friday, December 4, 2020. This educational activity will give oncology health care providers expert perspectives on the molecular pathogenesis of PTCL and CTCL, and their diagnosis and treatment. The renowned faculty will discuss optimization of currently available therapies, and emerging trends in new treatments. The live webcast will feature a multidisciplinary panel of hematology experts discussing cases, defining integration of lab results into clinical practice, and reviewing the application of novel agents in individualized patient care.

Benefits of Attending

  • Learn about the latest molecular testing for diagnosing PTCL tumor types
  • Hear experts discuss the safest treatment options for your patients with PTCL and CTCL
  • Learn about the latest emerging therapies for treating patients with PTCL and CTCL
  • Get the latest information on recognizing and managing adverse events from treatments for PTCL and CTCL

Acknowledgment of Commercial Support

This activity is supported by educational grants from Daiichi Sankyo, Inc., Seattle Genetics, and Takeda Oncology.

Target Audience

These activities are intended for medical oncologists, hematologists, and other oncology health care professionals interested in the latest advances in the treatment of patients with TCLs. Fellows, researchers, nurses, nurse practitioners, physician assistants, dermatologic oncologists, dermatologists, and other health care professionals interested in the treatment of patients with TCLs are also invited to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Discuss specific disease subtypes of TCLs and the role of molecular and phenotypic biomarkers for individualizing treatment decisions in patients with peripheral and cutaneous subtypes
  • Review efficacy and safety data for currently available options for the treatment of patients with PTCL and CTCL
  • Plan strategies for proactively recognizing, monitoring, and managing adverse events associated with treatment of PTCL and CTCL in the frontline setting and beyond
  • Review emerging novel therapies and strategies as well as the latest clinical trial data for the treatment of PTCL and CTCL

Program Chair

Steven Horwitzs, MD
Steven Horwitz, MD
Medical Oncologist
Associate Member
Memorial Sloan Kettering Cancer Center
New York, NY


2 Ways to Register
  1. Online: Click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).

Physicians' Education Resource®, LLC - ICIC19
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.

**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested through and including October 31, 2020, and a 50% fee on refunds requested on November 1, 2020 through November 28, 2020. No refunds will be made after November 30, 2019. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

Meeting information is accurate at the time of posting.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By